REFERENCES
2. Wu XK, Cong ZQ, Deng H. Research progress about anti-ganglioside in Guillain-Barré syndrome. J Apoplexy Nerv Dis 2013;30:1133-5.
3. Carr KR, Shah M, Garvin R, Shakir A, Jackson C. Post-Traumatic brain injury presenting with Guillain-Barré syndrome and elevalted anti-ganglioside antibodies: a case report and review of the literature. Int J Neurosci 2015;125:486-92.
4. Rivas S, Douds GL, Ostdahl RH, Harbaugh KS. Fulminant Guillain-Barré syndrome after closed head injury: a potentially reversible cause of an ominous examination. J Neurosurg 2008;108:595-600.
5. Wu Q, Liu N, Pan C, Bu B, Tang Z. Guillain-Barré syndrome and cerebral hemorrhage: two cases and literature review. Eur Neurol 2016;76:182-6.
6. Tan IL, Ng T, Vucic S. Sever Guillain-Barré syndrome following head trauma. J Clin Neurosci 2010;17:1452-4.
7. Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Dorrn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neuro 2014;10:469-82.
8. Wang YC, Feng GD, Wang J, Liu XD, Zhao G. Effect of conduction block in classification and prognosis of Guillain-Barre syndrome. Neuroimmunol Neuroinflammation 2014;1:77-81.
9. Kanda T. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J Neurol Neurosurg Psychiatry 2013;84:208-12.
10. Kanda T. Yamawaki M, Mizusawa H. Sera from Guillain-Barré patients enhance leakage in blood-nerve barrier model. Neurology 2003;60:301-6.
11. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury 2007;38:1392-400.
12. Shrikant P, Benveniste EN. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J Immunol 1996;157:1819-22.
13. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-8.
14. Willison HJ, Yuki N. Peripheral neuropathies and antiglycolipid antibodies. Brain 2002;125:2591-625.